{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:42:05Z","timestamp":1790998925675,"version":"4.1.0"},"reference-count":120,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Photodynamic therapy (PDT) can not only directly eliminate cancer cells, but can also stimulate antitumor immune responses. It also affects the expression of immune checkpoints. The purpose of this review is to collect, analyze, and summarize recent news about PDT and immune checkpoints, along with their inhibitors, and to identify future research directions that may enhance the effectiveness of this approach. A search for research articles published between January 2023 and March 2024 was conducted in PubMed\/MEDLINE. Eligibility criteria were as follows: (1) papers describing PDT and immune checkpoints, (2) only original research papers, (3) only papers describing new reports in the field of PDT and immune checkpoints, and (4) both in vitro and in vivo papers. Exclusion criteria included (1) papers written in a language other than Polish or English, (2) review papers, and (3) papers published before January 2023. 24 papers describing new data on PDT and immune checkpoints have been published since January 2023. These included information on the effects of PDT on immune checkpoints, and attempts to associate PDT with ICI and with other molecules to modulate immune checkpoints, improve the immunosuppressive environment of the tumor, and resolve PDT-related problems. They also focused on the development of new nanoparticles that can improve the delivery of photosensitizers and drugs selectively to the tumor. The effect of PDT on the level of immune checkpoints and the associated activity of the immune system has not been fully elucidated further, and reports in this area are divergent, indicating the complexity of the interaction between PDT and the immune system. PDT-based strategies have been shown to have a beneficial effect on the delivery of ICI to the tumor. The utility of PDT in enhancing the induction of the antitumor response by participating in the triggering of immunogenic cell death, the exposure of tumor antigens, and the release of various alarm signals that together promote the activation of dendritic cells and other components of the immune system has also been demonstrated, with the result that PDT can enhance the antitumor immune response induced by ICI therapy. PDT also enables multifaceted regulation of the tumor\u2019s immunosuppressive environment, as a result of which ICI therapy has the potential to achieve better antitumor efficacy. The current review has presented evidence of PDT\u2019s ability to modulate the level of immune checkpoints and the effectiveness of the association of PDT with ICIs and other molecules in inducing an effective immune response against cancer cells. However, these studies are at an early stage and many more observations need to be made to confirm their efficacy. The new research directions indicated may contribute to the development of further strategies.<\/jats:p>","DOI":"10.3390\/cimb46070430","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:14:41Z","timestamp":1720610081000},"page":"7239-7257","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Latest Look at PDT and Immune Checkpoints"],"prefix":"10.3390","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-6570","authenticated-orcid":false,"given":"David","family":"Aebisher","sequence":"first","affiliation":[{"name":"Department of Photomedicine and Physical Chemistry, Medical College, The Rzesz\u00f3w University, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3265-8990","authenticated-orcid":false,"given":"Agnieszka","family":"Przyg\u00f3rzewska","sequence":"additional","affiliation":[{"name":"English Division Science Club, Medical College of The Rzesz\u00f3w University, 35-025 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-5464","authenticated-orcid":false,"given":"Dorota","family":"Bartusik-Aebisher","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and General Chemistry, Medical College of The Rzesz\u00f3w University, 35-025 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Cheng, X., Wei, Y., Jiang, X., Wang, C., Liu, M., Yan, J., Zhang, L., and Zhou, Y. (2022). Insight into the Prospects for Tumor Therapy Based on Photodynamic Immunotherapy. Pharmaceuticals, 15.","DOI":"10.3390\/ph15111359"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Jin, H., Liao, S., Yao, F., Li, J., Xu, Z., Zhao, K., Xu, X., and Sun, S. (2023). Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer. Cancers, 15.","DOI":"10.3390\/cancers15051532"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wang, H., Ewetse, M.P., Ma, C., Pu, W., Xu, B., He, P., Wang, Y., Zhu, J., and Chen, H. (2022). The \u201cLight Knife\u201d for Gastric Cancer: Photodynamic Therapy. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010101"},{"key":"ref_4","first-page":"561","article-title":"Photodynamic combinational therapy in cancer treatment","volume":"23","author":"Zhang","year":"2018","journal-title":"J. BUON"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s43046-021-00093-1","article-title":"Implications of photodynamic cancer therapy: An overview of PDT mechanisms basically and practically","volume":"33","author":"Sobhani","year":"2021","journal-title":"J. Egypt Natl. Canc. Inst."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ma, Y., Xiao, F., Lu, C., and Wen, L. (2022). Multifunctional Nanosystems Powered Photodynamic Immunotherapy. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.905078"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jung, A.C., Moinard-Butot, F., Thibaudeau, C., Gasser, G., and Gaiddon, C. (2021). Antitumor Immune Response Triggered by Metal-Based Photosensitizers for Photodynamic Therapy: Where Are We?. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111788"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Jain, R., Mohanty, S., Sarode, I., Biswas, S., Singhvi, G., and Dubey, S.K. (2022). Multifunctional Photoactive Nanomaterials for Photodynamic Therapy against Tumor: Recent Advancements and Perspectives. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010109"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"45882","DOI":"10.1021\/acsomega.2c05852","article-title":"Nanotherapeutic Intervention in Photodynamic Therapy for Cancer","volume":"7","author":"Itoo","year":"2022","journal-title":"ACS Omega"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1871520620666200318101037","article-title":"Factors Affecting Photodynamic Therapy and Anti-Tumor Immune Response","volume":"21","author":"Hamblin","year":"2021","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dinakaran, D., and Wilson, B.C. (2023). The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1250804"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ulfo, L., Costantini, P.E., Di Giosia, M., Danielli, A., and Calvaresi, M. (2022). EGFR-Targeted Photodynamic Therapy. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14020241"},{"key":"ref_14","first-page":"100829","article-title":"Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: Novel insights and perspectives","volume":"18","author":"Wang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Olszowy, M., Nowak-Perlak, M., and Wo\u017aniak, M. (2023). Current Strategies in Photodynamic Therapy (PDT) and Photodynamic Diagnostics (PDD) and the Future Potential of Nanotechnology in Cancer Treatment. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15061712"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chou, W., Sun, T., Peng, N., Wang, Z., Chen, D., Qiu, H., and Zhao, H. (2023). Photodynamic Therapy-Induced Anti-Tumor Immunity: Influence Factors and Synergistic Enhancement Strategies. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15112617"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yang, Y.L., Lin, K., and Yang, L. (2021). Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111951"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shih, C.Y., Wang, P.T., Su, W.C., Teng, H., and Huang, W.L. (2021). Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020137"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shrestha, R., Mallik, S.K., Lim, J., Gurung, P., Magar, T.B.T., and Kim, Y.W. (2023). Efficient Synthesis of Chlorin e6 and Its Potential Photodynamic Immunotherapy in Mouse Melanoma by the Abscopal Effect. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043901"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s00262-023-03479-3","article-title":"TGF-\u03b21 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy","volume":"72","author":"Han","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/php.13173","article-title":"The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T-Cell Repertoire","volume":"95","author":"Nath","year":"2019","journal-title":"Photochem. Photobiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/978-1-0716-2099-1_29","article-title":"Measuring the Antitumor T-Cell Response in the Context of Photodynamic Therapy","volume":"2451","author":"Kleinovink","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7150\/thno.67300","article-title":"Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy","volume":"12","author":"Ji","year":"2022","journal-title":"Theranostics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e001926","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: Past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2201734","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Dao, A., Yadav, A.K., Wei, L., Banerjee, S., and Huang, H. (2022). Combination of Immunotherapy and Photo-pyroptosis as Novel Anticancer Strategy. ChemBioChem, 23.","DOI":"10.1002\/cbic.202200201"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/978-1-0716-2099-1_30","article-title":"Combination of Photodynamic Therapy and Immune Checkpoint Blockade","volume":"2451","author":"Kleinovink","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hua, J., Wu, P., Gan, L., Zhang, Z., He, J., Zhong, L., Zhao, Y., and Huang, Y. (2021). Current Strategies for Tumor Photodynamic Therapy Combined with Immunotherapy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.738323"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1905825","DOI":"10.1002\/adma.201905825","article-title":"Activating Antitumor Immunity and Antimetastatic Effect Through Polydopamine-Encapsulated Core-Shell Upconversion Nanoparticles","volume":"31","author":"Yan","year":"2019","journal-title":"Adv. Mater."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.2147\/IJN.S314506","article-title":"Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death","volume":"16","author":"Jin","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.7150\/thno.80091","article-title":"Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy","volume":"13","author":"Yin","year":"2023","journal-title":"Theranostics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/s12967-022-03707-x","article-title":"A photodynamically sensitized dendritic cell vaccine that promotes the anti-tumor effects of anti-PD-L1 monoclonal antibody in a murine model of head and neck squamous cell carcinoma","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-018-0022-9","article-title":"The intracellular signalosome of PD-L1 in cancer cells","volume":"3","author":"Escors","year":"2018","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chocarro de Erauso, L., Zuazo, M., Arasanz, H., Bocanegra, A., Hernandez, C., Fernandez, G., Garcia-Granda, M.J., Blanco, E., Vera, R., and Kochan, G. (2020). Resistance to PD-L1\/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00441"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1038\/s41598-023-30256-0","article-title":"Chlorin e6-associated photodynamic therapy enhances abscopal antitumor effects via inhibition of PD-1\/PD-L1 immune checkpoint","volume":"13","author":"Gurung","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1038\/s41598-023-38862-8","article-title":"Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming","volume":"13","author":"Lobo","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"103983","DOI":"10.1016\/j.pdpdt.2024.103983","article-title":"Combination of vitamin D and photodynamic therapy enhances immune responses in murine models of squamous cell skin cancer","volume":"45","author":"Anand","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wang, Q., Xie, B., Liu, S., Shi, Y., Tao, Y., Xiao, D., and Wang, W. (2021). What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.773168"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41590-021-01125-7","article-title":"PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity","volume":"23","author":"Sugiura","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Delcanale, P., Alampi, M.M., Mussini, A., Fumarola, C., Galetti, M., Petronini, P.G., Viappiani, C., Bruno, S., and Abbruzzetti, S. (2023). A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15122776"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1021\/jacs.6b06663","article-title":"Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy","volume":"138","author":"Lu","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Liu, X., Liu, X., Yu, J., Bai, X., Wu, X., Guo, X., Liu, Z., and Liu, X. (2022). Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.955920"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Li, Q., Han, J., Yang, Y., and Chen, Y. (2022). PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1070961"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Aebisher, D., Wo\u017anicki, P., and Bartusik-Aebisher, D. (2024). Photodynamic Therapy and Adaptive Immunity Induced by Reactive Oxygen Species: Recent Reports. Cancers, 16.","DOI":"10.3390\/cancers16050967"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.18632\/aging.202355","article-title":"The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumors","volume":"13","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/php.13300","article-title":"Photodynamic Therapy and Immune Checkpoint Blockade","volume":"96","author":"Cramer","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Yue, J., Mei, Q., Wang, P., Miao, P., Dong, W.F., and Li, L. (2022). Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy. J. Nanobiotechnol., 20.","DOI":"10.1186\/s12951-022-01388-8"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lou, J., Aragaki, M., Bernards, N., Chee, T., Gregor, A., Hiraishi, Y., Ishiwata, T., Leung, C., Ding, L., and Kitazawa, S. (2023). Repeated photodynamic therapy mediates the abscopal effect through multiple innate and adaptive immune responses with and without immune checkpoint therapy. Biomaterials, 292.","DOI":"10.1016\/j.biomaterials.2022.121918"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/713774061","article-title":"Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells","volume":"9","author":"Eppihimer","year":"2002","journal-title":"Microcirculation"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Bhandari, C., Moffat, A., Fakhry, J., Malkoochi, A., Nguyen, A., Trinh, B., Hoyt, K., Story, M.D., Hasan, T., and Obaid, G. (2023). A single photodynamic priming protocol augments delivery of \u237a-PD-L1 mAbs and induces immunogenic cell death in head and neck tumors. Photochem. Photobiol., 11.","DOI":"10.1111\/php.13865"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10555-022-10064-0","article-title":"Increasing cancer permeability by photodynamic priming: From microenvironment to mechanotransduction signaling","volume":"41","author":"Arifi","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e2206932","DOI":"10.1002\/advs.202206932","article-title":"Near-Infrared-II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/thy.2021.0371","article-title":"Lenvatinib Plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic. Model of Thyroid Cancer","volume":"32","author":"Bertol","year":"2022","journal-title":"Thyroid"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJMoa2108330","article-title":"Study 309\u2013KEYNOTE-775 Investigators. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer","volume":"386","author":"Makker","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.19.02627","article-title":"Lenvatinib Plus Pembrolizumab in Patients With. Advanced Endometrial Cancer","volume":"38","author":"Makker","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41419-021-03745-1","article-title":"Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1-PD-L1+ Bregs through PD-L1\/PI3K\/AKT\/NF-\u03baB axis in breast cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e1247135","DOI":"10.1080\/2162402X.2016.1247135","article-title":"The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells","volume":"5","author":"Lu","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-18-1390","article-title":"Antibody-Fc\/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1\/PD-L1 Blockade","volume":"25","author":"Moro","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e2307147","DOI":"10.1002\/smll.202307147","article-title":"Engineered Extracellular Vesicles Expressing Siglec-10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor-Associated Antigens for Photodynamic Immunotherapy","volume":"20","author":"Sun","year":"2023","journal-title":"Small"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s00262-023-03488-2","article-title":"SIGLEC10+ macrophages drive gastric cancer progression by suppressing CD8+ T cell function","volume":"72","author":"Guo","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Wang, H., Feng, Y., Zhang, Y., Wang, T., Xu, H., Zhi, Y., Feng, Y., Tian, L., and Yuan, K. (2022). Siglec10-An immunosuppressor and negative predictor of survival prognosis in gliomas. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.873655"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00262-023-03606-0","article-title":"Targeting CD24\/Siglec-10 signal pathway for cancer immunotherapy: Recent advances and future directions","volume":"73","author":"Li","year":"2024","journal-title":"Cancer Immunol Immunother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e2306748","DOI":"10.1002\/adma.202306748","article-title":"Augmenting Immunotherapy via Bioinspired MOF-Based ROS Homeostasis Disruptor with Nanozyme-Cascade Reaction","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"102461","DOI":"10.1016\/j.ctrv.2022.102461","article-title":"Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy","volume":"110","author":"Fujiwara","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Zhai, L., Bell, A., Ladomersky, E., Lauing, K.L., Bollu, L., Sosman, J.A., Zhang, B., Wu, J.D., Miller, S.D., and Meeks, J.J. (2020). Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01185"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e2205694","DOI":"10.1002\/smll.202205694","article-title":"Cascade Immune Activation of Self-Delivery Biomedicine for Photodynamic Immunotherapy Against Metastatic Tumor","volume":"19","author":"Zheng","year":"2023","journal-title":"Small"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): A randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e202214750","DOI":"10.1002\/anie.202214750","article-title":"PD-L1 Aptamer-Functionalized Metal-Organic Framework Nanoparticles for Robust Photo-Immunotherapy against Cancer with Enhanced Safety","volume":"62","author":"Zhang","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1021\/acs.biomac.2c01416","article-title":"Mitochondria-Targeting and Multiresponsive Nanoplatform Based on AIEgens for Synergistic Chemo-Photodynamic Therapy and Enhanced Immunotherapy","volume":"24","author":"Feng","year":"2023","journal-title":"Biomacromolecules"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"910","DOI":"10.21147\/j.issn.1000-9604.2019.06.07","article-title":"Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma","volume":"31","author":"Zhang","year":"2019","journal-title":"Chin. J. Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Yao, D., Wang, Y., Bian, K., Zhang, B., and Wang, D. (2023). A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer. Biomaterials, 292.","DOI":"10.1016\/j.biomaterials.2022.121920"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: The TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","article-title":"IDO\/kynurenine pathway in cancer: Possible therapeutic approaches","volume":"20","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Yang, J., Guo, W., Huang, R., Bian, J., Zhang, S., Wei, T., He, C., Hu, Z., Li, J., and Zhou, C. (2023). Self-assembled albumin nanoparticles induce pyroptosis for photodynamic\/photothermal\/immuno synergistic therapies in triple-negative breast cancer. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1173487"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","article-title":"Role of pyroptosis in inflammation and cancer","volume":"19","author":"Wei","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Fang, Y., Tian, S., Pan, Y., Li, W., Wang, Q., Tang, Y., Yu, T., Wu, X., Shi, Y., and Ma, P. (2020). Pyroptosis: A new frontier in cancer. Biomed. Pharmacother., 121.","DOI":"10.1016\/j.biopha.2019.109595"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijrobp.2022.07.1841","article-title":"Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells","volume":"115","author":"Cao","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"948","DOI":"10.20892\/j.issn.2095-3941.2022.0049","article-title":"Eliciting pyroptosis to fuel cancer immunotherapy: Mechanisms and strategies","volume":"19","author":"Wang","year":"2022","journal-title":"Cancer Biol. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Gan, Y., Li, X., Han, S., Liang, Q., Ma, X., Rong, P., Wang, W., and Li, W. (2022). The cGAS\/STING\u2002Pathway: A Novel Target for Cancer Therapy. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.795401"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Larue, L., Myrzakhmetov, B., Ben-Mihoub, A., Moussaron, A., Thomas, N., Arnoux, P., Baros, F., Vanderesse, R., Acherar, S., and Frochot, C. (2019). Fighting Hypoxia to Improve PDT. Pharmaceuticals, 12.","DOI":"10.3390\/ph12040163"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1021\/acsnano.3c07002","article-title":"Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy","volume":"18","author":"Qu","year":"2024","journal-title":"ACS Nano"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ccell.2022.10.001","article-title":"Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/2326-6066.CIR-22-0121","article-title":"Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade","volume":"11","author":"Pearce","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1039\/D3TB00384A","article-title":"A carbon dot-doped Cu-MOF-based smart nanoplatform for enhanced immune checkpoint blockade therapy and synergistic multimodal cancer therapy","volume":"11","author":"Su","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e139434","DOI":"10.1172\/JCI139434","article-title":"TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis","volume":"131","author":"Jiang","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: A novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e2300994","DOI":"10.1002\/adhm.202300994","article-title":"Photo-Enhanced Synergistic Induction of Ferroptosis for Anti-Cancer Immunotherapy","volume":"12","author":"Zhou","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","article-title":"Ferroptosis of tumour neutrophils causes immune suppression in cancer","volume":"612","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e2307870","DOI":"10.1002\/advs.202307870","article-title":"Enhanced Photodynamic Therapy Synergizing with Inhibition of Tumor Neutrophil Ferroptosis Boosts Anti-PD-1 Therapy of Gastric Cancer","volume":"11","author":"Zhu","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1021\/acs.molpharmaceut.3c00186","article-title":"PD-L1 Blockade Peptide-Modified Polymeric Nanoparticles for Oxygen-Independent-Based Hypoxic Tumor Photo\/Thermodynamic Immunotherapy","volume":"20","author":"Gu","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1021\/nl400188q","article-title":"Subnanometer local temperature probing and remotely controlled drug release based on azo-functionalized iron oxide nanoparticles","volume":"13","author":"Riedinger","year":"2013","journal-title":"Nano Lett."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-021-01102-5","article-title":"The relationship between expression of PD-L1 and HIF-1\u03b1 in glioma cells under hypoxia","volume":"14","author":"Ding","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: A novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jconrel.2023.04.027","article-title":"Targeting glutamine metabolism with photodynamic immunotherapy for metastatic tumor eradication","volume":"357","author":"Zhao","year":"2023","journal-title":"J. Control Release"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm.4464","article-title":"Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models","volume":"24","author":"Schulte","year":"2018","journal-title":"Nat. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14728222.2019.1627328","article-title":"ASCT2: A potential cancer drug target","volume":"23","author":"Wahi","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Tang, Q., Chen, Y., Li, X., Long, S., Shi, Y., Yu, Y., Wu, W., Han, L., and Wang, S. (2022). The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.964442"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Qiu, Z., Lu, Z., Huang, J., Zhong, Y., Yan, N., Kong, R., and Cheng, H. (2023). Self-reinforced photodynamic immunostimulator to downregulate and block PD-L1 for metastatic breast cancer treatment. Biomaterials, 303.","DOI":"10.1016\/j.biomaterials.2023.122392"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: A small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Zerdes, I., Wallerius, M., Sifakis, E.G., Wallmann, T., Betts, S., Bartish, M., Tsesmetzis, N., Tobin, N.P., Coucoravas, C., and Bergh, J. (2019). STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer. Cancers, 11.","DOI":"10.3390\/cancers11101479"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40199-020-00326-z","article-title":"STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells","volume":"28","author":"Jafari","year":"2020","journal-title":"Daru"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/acsnano.3c10117","article-title":"Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-\u03b2 to Overcome Photodynamic Immunotherapy Resistance","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Mohd Idris, R.A., Mussa, A., Ahmad, S., Al-Hatamleh, M.A.I., Hassan, R., Tengku Din, T.A.D.A.A., Wan Abdul Rahman, W.F., Lazim, N.M., Boer, J.C., and Plebanski, M. (2022). The Effects of Tamoxifen on Tolerogenic Cells in Cancer. Biology, 11.","DOI":"10.3390\/biology11081225"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Yi, M., Li, T., Niu, M., Wu, Y., Zhao, Z., and Wu, K. (2022). TGF-\u03b2: A novel predictor and target for anti-PD-1\/PD-L1 therapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1061394"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e2301401","DOI":"10.1002\/adhm.202301401","article-title":"A Trojan Horse Delivery Vehicle Carrying siRNA Nanotherapeutics with Multiple Tumor Microenvironment Responsiveness Elicits Robust Antitumor Immune Responses In Situ via a \u201cSelf-Synergistic\u201d Approach","volume":"12","author":"Fang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"109022","DOI":"10.1016\/j.intimp.2022.109022","article-title":"A review of PD-1\/PD-L1 siRNA delivery systems in immune T cells and cancer cells","volume":"111","author":"Barati","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Zhang, M.M., Bahal, R., Rasmussen, T.P., Manautou, J.E., and Zhong, X.B. (2021). The growth of siRNA-based therapeutics: Updated clinical studies. Biochem. Pharmacol., 189.","DOI":"10.1016\/j.bcp.2021.114432"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Morita, M., Okuyama, M., Akutsu, T., Ohdaira, H., Suzuki, Y., and Urashima, M. (2021). Vitamin D Supplementation Regulates Postoperative Serum Levels of PD-L1 in Patients with Digestive Tract Cancer and Improves Survivals in the Highest Quintile of PD-L1: A Post Hoc Analysis of the AMATERASU Randomized Controlled Trial. Nutrients, 13.","DOI":"10.3390\/nu13061987"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2024.02.030","article-title":"Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief","volume":"368","author":"He","year":"2024","journal-title":"J. Control Release."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Tan, S., Yu, J., Huang, Q., Zhou, N., and Gou, H. (2022). PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1006075"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1039\/D3BM00248A","article-title":"Multi-shell structured upconversion nanocarriers that combine IDO inhibitor-induced immunotherapy with NIR-triggered photodynamic therapy for deep tumors","volume":"11","author":"Choi","year":"2023","journal-title":"Biomater. Sci."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/46\/7\/430\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:34:45Z","timestamp":1767947685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/46\/7\/430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":120,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["cimb46070430"],"URL":"https:\/\/doi.org\/10.3390\/cimb46070430","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]}}}